Minerva Neurosciences, Inc. Effective Income Tax Rate Reconciliation, Deduction, Percent
Minerva Neurosciences, Inc. (NERV) reported Effective Income Tax Rate Reconciliation, Deduction, Percent of -14.99% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductions · last filed 2026-03-11
- Minerva Neurosciences, Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2024 was -14.99%, a 2729.82% decline from fiscal 2023.
- Minerva Neurosciences, Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2023 was 0.57%.
- Minerva Neurosciences, Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2022 was -0.08%.
- Minerva Neurosciences, Inc. effective income tax rate reconciliation, deduction, percent for fiscal 2021 was -0.30%, a 106.85% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Percent 12 month | Effective Income Tax Rate Reconciliation, Deduction, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -14.99% 10-K · filed 2026-03-11 | |
| 2023-12-31 | 0.57% 10-K · filed 2025-02-25 | -0.57% 10-K · filed 2024-02-22 |
| 2022-12-31 | -0.08% 10-K · filed 2024-02-22 | |
| 2021-12-31 | -0.30% 10-K · filed 2023-03-08 | |
| 2020-12-31 | 4.38% 10-K · filed 2022-03-01 | |
| 2019-12-31 | -0.37% 10-K · filed 2021-03-08 | |
| 2018-12-31 | 0.38% 10-K · filed 2020-03-09 | |
| 2017-12-31 | 0.66% 10-K · filed 2019-03-12 | |
| 2016-12-31 | 0.76% 10-K · filed 2018-03-12 | |
| 2015-12-31 | 0.53% 10-K · filed 2018-03-12 | |
| 2014-12-31 | 4.27% 10-K · filed 2017-03-13 | |
| 2013-12-31 | -2.49% 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |